Lantheus Medical Imaging Inc. said Wednesday it promoted Cyrille Villeneuve to chief commercial officer and Dr. Dana Washburn to chief medical officer.

Villeneuve, previously vice president and general manager, international, will now direct the N. Billerica, Mass.-based radiopharmaceutical company's global commercial strategy. Vileneuve has been with Lantheus since 1985, when it was still owned by E.I. du Pont de Nemours and Company, and before its sale to Bristol-Myers Squibb Company and later purchase by Avista Capital Partners.


Washburn joined Lantheus last year as vice president, clinical development and medical affairs. Don Kiepert, Lantheus' president and CEO, said he made a big impact on the company's flurpiridaz F-18 radiotracer research, which began phase III clinical trials in June.
"His deep industry experience and work as a practicing nuclear cardiologist make him ideal for our new position of chief medical officer," Kiepert said in a statement.

More Voices